Chen, H., Li, X., Li, W., & Zheng, H. (2015). miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase. J Transl Med.
Chicago ZitierstilChen, Huiyuan, Xinyi Li, Wenbin Li, und Huyong Zheng. "MiR-130a Can Predict Response to Temozolomide in Patients With Glioblastoma Multiforme, Independently of O6-methylguanine-DNA Methyltransferase." J Transl Med 2015.
MLA ZitierstilChen, Huiyuan, Xinyi Li, Wenbin Li, und Huyong Zheng. "MiR-130a Can Predict Response to Temozolomide in Patients With Glioblastoma Multiforme, Independently of O6-methylguanine-DNA Methyltransferase." J Transl Med 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.